# Nemonoxacin

## Taigexyn 250mg

| TAH Drug Code      | [OTAI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OTAI)                                                                                                                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Indicated for the treatment of infections in adults caused by pathogens susceptible to nemonoxacin: suitable for outpatient treatment of mild community-acquired pneumonia.                                                                                                                                                             |
| Dosing             | Adults: 500mg (2 capsules) once a day on an empty stomach (take at least two hours before or at least two hours after eating) for 7-10 days.                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Contraindicated in patients known to be allergic to any component of this medication or other quinolones, pregnant or breastfeeding women, and children or adolescents.                                                                                                                                                                 |
| Adverse Effects    | Gastrointestinal Diseases: Nausea (2.5%), Diarrhea (1.3%), Vomiting (1.2%) Blood and Lymphatic System Diseases: Neutropenia (1.9%) Nervous system diseases: Dizziness (1.9%), Headache (1.0%) Other: ALT (SGPT) increased (4.4%), Reduction in white blood cell count (2.1%), AST (SGOT) increased (1.9%), AST (SGOT) increased ( 1.9%) |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/nemonoxacin-drug-information)                                                                                                                                                                                                                                                              |

